Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Lenzetto® 1.53mg/dose transdermal spray is now available to meet normal demand. As a result the following Serious Shortage Protocols, will expire at 23.59pm on Friday 13 January 2023. After this date, any prescriptions for Lenzetto® 1.53mg/dose transdermal spray must be dispensed in accordance with the prescription, and the SSPs will no longer be valid for use.

SSP
Expiry Date
Supporting Information
SSP026 Lenzetto® 1.53mg/dose transdermal spray – restriction
13 January 2023
SSP026 guide
SSP027 Lenzetto® 1.53mg/dose transdermal spray – substitution
13 January 2023
SSP027 guide
SSP028 Lenzetto® 1.53mg/dose transdermal spray – substitution and restriction
13 January 2023
SSP028 guide

Top tips for SSP claims

Where available, use the claim amend facility on the PMR system to rectify any incorrect EPS claims already submitted this month.
Any paper prescriptions with SSP claims need to be placed in the red separator provided by the NHSBSA.
For any supplies made in accordance with SSPs, check that the correct number of patient charges are collected and declared on the end of month FP34C submission document.
Although an SSP cannot be used outside its period of validity, claims can be submitted up to three calendar months after expiry or withdrawal of the SSP.
NHSBSA advise that contractors must follow the specific endorsement guidance issued with each SSP and endorsements should be clear and unambiguous – NHSBSA processing staff must be able to determine what has been supplied.
Pharmacy contractors should keep a record of all SSP claims submitted each month to reconcile against their monthly Schedule of Payments or Prescription Item (Px) reports.
View our SSP submission guidance to ensure your SSP claims are appropriately submitted to NHSBSA for reimbursement.